PlainPharmaWatch

CMS Open Payments · Program Year 2024

imvaria inc.

imvaria inc. reported $1,421.83 across General Payments, Research, and Ownership to 5 physicians and teaching hospitals across 5 transactions.

$1.4K Below-median payer
All-tracks total
5 Below-median volume
Transactions
5 Below-median reach
Recipients
#1828
of 1,925 companies

imvaria inc. reported $1,421.83 across all CMS Open Payments tracks (General + Research + Ownership) to 5 physicians and teaching hospitals in Program Year 2024 - ranking #1828 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,421.83, averaging $284.37 per recipient.

imvaria inc.'s payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

10/100

Total payments

F

10/100

Transaction volume

F

10/100

Physician reach

F

10/100

Payment type diversity

F

10/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer imvaria-inc imvaria inc.

$1.4K · #1828/1,925 · 0.0% industry · PY2024

  • TOT $1.4K
  • RANK #1828
  • SHARE 0.0%
  • TXN 5
  • RCP 5
  • CAT 1
  • GEN $1.4K
  • TOP1 30.5%
  • PY 2024

Nearest volume peer: Aspero Medical, Inc. ($1.4K)

Medtec LLC$1.5KOmeza LLC$1.5KDiality Inc.$1.5KAspero Medical, Inc.$1.4Kimvaria inc. (this)$1.4K
All-tracks payment totals near imvaria inc. (CMS Open Payments PY2024)

imvaria inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for imvaria inc.

Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For imvaria inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.

Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $1.4K across 5 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Food and Beverage" leads imvaria inc.'s 1-category general-payment breakdown at $1.4K, 100.0% of the reported total.

How imvaria inc. divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$1.4K
Payment Type Amount Transactions
Food and Beverage $1.4K 5

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,421.83 (100.0%) of $1,421.83 in this company's General Payments records across 5 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for imvaria inc.

The five named recipients with the highest reported General Payments from this company

Sunil SANTHANAKRISHNAN$434.33Robert Cobb$314.35Michael Czarnecki$236.52James Pharaoh$236.52Eric Weaver$200.11
  1. 1

    Sunil SANTHANAKRISHNAN

    $434.33 across 1 reported transactions

  2. 2

    Robert Cobb

    $314.35 across 1 reported transactions

  3. 3

    Michael Czarnecki

    $236.52 across 1 reported transactions

  4. 4

    James Pharaoh

    $236.52 across 1 reported transactions

  5. 5

    Eric Weaver

    $200.11 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

imvaria inc. ranks #1828 of 1,925 by total payments (bottom 5% by spend) but is notably more concentrated than that alone would suggest -- #723 of 1,838 by HHI (top 39% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.

00.30.50.81.12128.62147.52166.52185.52204.4Total payments ($M)Concentration (HHI, 0-10,000)
imvaria inc. (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as imvaria inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about imvaria inc..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with imvaria inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

imvaria inc. ranks #1828 of 1,925 by all-tracks total payments, led by "Food and Beverage".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download imvaria inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.